Literature DB >> 15779086

Activation of catechol-O-methyltransferase in astrocytes stimulates homocysteine synthesis and export to neurons.

Guowei Huang1, Magdalena Dragan, David Freeman, John X Wilson.   

Abstract

Elevation of the total homocysteine (tHcy) concentration in plasma has been implicated in neurodegeneration in patients with stroke, dementia, Alzheimer disease, and Parkinson disease. Because the mechanisms controlling brain tHcy are unknown, the present study investigated its synthesis and transport in primary rat brain cell cultures. We found that the catechol-O-methyltransferase (COMT) substrate 3,4-dihydroxybenzoic acid (DHB) increased export of tHcy in astrocytes, but not in neurons. The export mechanism was selective for tHcy over cyst(e)ine, total glutathione (tGSH) or cysteinylglycine (Cys-Gly). tHcy export from astrocytes was also induced by the COMT substrates levodopa (L-DOPA), dopamine and quercetin, and it was blocked by the COMT inhibitors tropolone and entacapone. This export was associated with increased synthesis of tHcy because both intracellular and extracellular tHcy concentrations rose during COMT activation. Incubation in cyst(e)ine-deficient medium inhibited the tHcy export response to COMT activation. Exogenous tHcy (100 muM) was accumulated into neurons, but not into astrocytes. We conclude that activation of COMT causes sustained synthesis of Hcy in astrocytes and transport of this amino acid to neurons. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15779086     DOI: 10.1002/glia.20185

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  15 in total

1.  Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson's disease patients.

Authors:  Thomas Müller; Wilfried Kuhn
Journal:  Eur J Clin Pharmacol       Date:  2006-04-22       Impact factor: 2.953

2.  Gestational vitamin B deficiency leads to homocysteine-associated brain apoptosis and alters neurobehavioral development in rats.

Authors:  Sébastien A Blaise; Emmanuelle Nédélec; Henri Schroeder; Jean-Marc Alberto; Carine Bossenmeyer-Pourié; Jean-Louis Guéant; Jean-Luc Daval
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Possible treatment concepts for the levodopa-related hyperhomocysteinemia.

Authors:  Thomas Müller
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-09

4.  Association of Hippocampal Atrophy With Duration of Untreated Psychosis and Molecular Biomarkers During Initial Antipsychotic Treatment of First-Episode Psychosis.

Authors:  Donald C Goff; Botao Zeng; Babak A Ardekani; Erica D Diminich; Yingying Tang; Xiaoduo Fan; Isaac Galatzer-Levy; Chenxiang Li; Andrea B Troxel; Jijun Wang
Journal:  JAMA Psychiatry       Date:  2018-04-01       Impact factor: 21.596

5.  Homocysteine and A2A-D2 Receptor-Receptor Interaction at Striatal Astrocyte Processes.

Authors:  Chiara Cervetto; Arianna Venturini; Diego Guidolin; Guido Maura; Mario Passalacqua; Carlo Tacchetti; Pietro Cortelli; Susanna Genedani; Simona Candiani; Paola Ramoino; Simone Pelassa; Manuela Marcoli; Luigi F Agnati
Journal:  J Mol Neurosci       Date:  2018-07-20       Impact factor: 3.444

6.  Chronic inflammation alters production and release of glutathione and related thiols in human U373 astroglial cells.

Authors:  Megan L Steele; Stacey Fuller; Annette E Maczurek; Cindy Kersaitis; Lezanne Ooi; Gerald Münch
Journal:  Cell Mol Neurobiol       Date:  2012-07-31       Impact factor: 5.046

7.  Folic acid attenuates the effects of amyloid β oligomers on DNA methylation in neuronal cells.

Authors:  Huan Liu; Wen Li; Shijing Zhao; Xumei Zhang; Meilin Zhang; Yanyu Xiao; John X Wilson; Guowei Huang
Journal:  Eur J Nutr       Date:  2015-07-30       Impact factor: 5.614

8.  Homocysteine reduces NMDAR desensitization and differentially modulates peak amplitude of NMDAR currents, depending on GluN2 subunit composition.

Authors:  Andrew D Bolton; Marnie A Phillips; Martha Constantine-Paton
Journal:  J Neurophysiol       Date:  2013-07-17       Impact factor: 2.714

9.  Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications.

Authors:  David Braun; Jose L M Madrigal; Douglas L Feinstein
Journal:  Curr Neuropharmacol       Date:  2014-07       Impact factor: 7.363

10.  Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference.

Authors:  Thomas Müller
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.